当前位置: 首页 >> 检索结果
202. Screening for Syphilis Infection During Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
作者: Gary N Asher.;Meera Viswanathan.;Afua Takyi.;Jennifer Cook Middleton.;Claire Baker.;Leila C Kahwati.
来源: JAMA. 2025年333卷22期2015-2017页 203. Screening for Syphilis Infection During Pregnancy: US Preventive Services Task Force Reaffirmation Recommendation Statement.
作者: .;Michael Silverstein.;John B Wong.;Esa M Davis.;David Chelmow.;Tumaini Rucker Coker.;Alicia Fernandez.;Ericka Gibson.;Carlos Roberto Jaén.;Marie Krousel-Wood.;Sei Lee.;Wanda K Nicholson.;Goutham Rao.;John M Ruiz.;James Stevermer.;Joel Tsevat.;Sandra Millon Underwood.;Sarah Wiehe.
来源: JAMA. 2025年333卷22期2006-2012页
Untreated syphilis infection during pregnancy can be passed to the fetus, causing congenital syphilis. Congenital syphilis is associated with premature birth, low birth weight, stillbirth, neonatal death, and significant abnormalities in the infant such as deformed bones, anemia, enlarged liver and spleen, jaundice, brain and nerve problems (eg, permanent vision or hearing loss), and meningitis. In 2023, there were 3882 cases of congenital syphilis in the US, including 279 congenital syphilis-related stillbirths and neonatal/infant deaths, the highest number reported in more than 30 years.
209. The Microbiome and Cancer: A Translational Science Review.
Growing evidence suggests that microbes located within the gastrointestinal tract and other anatomical locations influence the development and progression of diseases such as cancer.
212. Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial.
作者: Scott R Garrison.;Jeffrey A Bakal.;Michael R Kolber.;Christina S Korownyk.;Lee A Green.;Jessica E M Kirkwood.;Finlay A McAlister.;Raj S Padwal.;Richard Lewanczuk.;Michael D Hill.;Alexander G Singer.;Alan Katz.;Michael D Kelmer.;Armine Gayayan.;Farah N Campbell.;Ana Vucenovic.;Nathan R Archibald.;Jack M S Yeung.;Erik R E Youngson.;Kimberlyn McGrail.;Braden G O'Neill.;Michelle Greiver.;Donna P Manca.;Roni Y Kraut.;Ting Wang.;Braden J Manns.;Dee A Mangin.;Cathy MacLean.;James McCormack.;Sabrina T Wong.;Colleen Norris.;G Michael Allan.
来源: JAMA. 2025年333卷23期2061-2072页
Whether administration of blood pressure medications at bedtime instead of in the morning reduces cardiovascular risk is unknown, as findings from large clinical trials have not been consistent. There is also concern that bedtime antihypertensive use could induce glaucoma-related visual loss or other hypotensive/ischemic adverse effects.
|